Evidence map›Paper›PMID 26476506›Full record

Trial reportJACC. Cardiovascular imaging2015

hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial.

Maros Ferencik, Ting Liu, Thomas Mayrhofer, Stefan B Puchner, Michael T Lu, Pal Maurovich-Horvat, J Hector Pope, Quynh A Truong, James E Udelson, W Frank Peacock and 6 more

2 registry-linked trialsOpen access · greenAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JACC. Cardiovascular imaging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01084239 phase3completednot on this map

Rule Out Myocardial Ischemia/Infarction by Computer Assisted Tomography

TypeinterventionalSponsorMassachusetts General HospitalRan2010 to 2012Enrolled1,000ConditionsAcute Coronary Syndrome, Myocardial Infarction, Unstable Angina PectorisArmsCardiac Computed Tomography
NCT03583320 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Prospective RandOmised Trial of Emergency Cardiac CT

TypeinterventionalSponsorGuy's and St Thomas' NHS Foundation TrustRan2018 to 2020Enrolled250ConditionsChest Pain, Coronary Artery Disease, Acute Coronary Syndrome, Ischemic Heart DiseaseArmsCardiac CT angiogram
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2021
    Trial
  3. Biomarkers of Cardiovascular Stress: A Historical Review.Journal of cardiovascular development and disease · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Utility of Cardiovascular CT in Ischemic Heart Disease.Echocardiography (Mount Kisco, N.Y.) · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 4 countries.

Maros Ferencik *Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR.
Ting Liu *Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Thomas MayrhoferDepartment of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Stefan B PuchnerDepartment of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Michael T LuDepartment of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Pal Maurovich-HorvatTA-SE Lendület Cardiovascular Imaging Research Group, Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.
J Hector PopeDepartment of Emergency Medicine, Baystate Medical Center, Springfield, MA.
Quynh A TruongDepartment of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
James E UdelsonDivision of Cardiology and the Cardio-Vascular Center, Tufts Medical Center, Boston, MA.
W Frank PeacockDepartment of Emergency Medicine, Baylor College of Medicine, Houston, TX.
Charles S WhiteUniversity of Maryland School of Medicine, Baltimore, MD.
Pamela K WoodardMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO.
Jerome L FlegDivision of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD.
John T NagurneyDepartment of Emergency Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
James L JanuzziCardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Udo HoffmannDepartment of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Harvard University · USBaylor College of Medicine · USBaystate Medical Center · USMallinckrodt (United States) · USNational Heart Lung and Blood Institute · USNewYork–Presbyterian Hospital · USSemmelweis University · HUTufts Medical Center · USUniversity of Maryland, Baltimore · US

Funding

ROMICAT II - CCC - Lead ApplicationU01HL092040 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HOFFMANN, UDO · 2009 to 2013
$4.9M
Cardiac MR and CT ResearchT32HL076136 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NEILAN, TOMAS G · 2004 to 2019
$4.9M
Cardiac MDCT for Early Triage of Patients with ACSR01HL080053 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HOFFMANN, UDO · 2006 to 2008
$1.5M
Rule-Out Myocardial Infarction Using Computed Assisted Tomography-ROMICATII,DCCU01HL092022 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SCHOENFELD, DAVID ALAN · 2009 to 2012
$1.2M
Cardiovascular Imaging in Ischemic Heart DiseaseK24HL113128 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HOFFMANN, UDO · 2012 to 2020
$1.1M
Computed Tomography to Predict Response to Cardiac Resynchronization TherapyK23HL098370 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI TRUONG, QUYNH A. · 2010 to 2014
$816k
NHLBI NIH HHS K23 HL098370NHLBI NIH HHS K24 HL113128NHLBI NIH HHS R01 HL080053NHLBI NIH HHS T32 HL076136NHLBI NIH HHS U01 HL092022NHLBI NIH HHS U01HL092022NHLBI NIH HHS U01 HL092040NHLBI NIH HHS U01HL092040
6 · The paper itself

Abstract

objectivesThis study compared diagnostic accuracy of conventional troponin/traditional coronary artery disease (CAD) assessment and highly sensitive troponin (hsTn) I/advanced CAD assessment for acute coronary syndrome (ACS) during the index hospitalization.

backgroundhsTnI and advanced assessment of CAD using coronary computed tomography angiography (CTA) are promising candidates to improve the accuracy of emergency department evaluation of patients with suspected ACS.

methodsWe performed an observational cohort study in patients with suspected ACS enrolled in the ROMICAT II (Rule Out Myocardial Infarction/Ischemia using Computer Assisted Tomography) trial and randomized to coronary CTA who also had hsTnI measurement at the time of the emergency department presentation. We assessed coronary CTA for traditional (no CAD, nonobstructive CAD, ≥50% stenosis) and advanced features of CAD (≥50% stenosis, high-risk plaque features: positive remodeling, low <30-Hounsfield units plaque, napkin-ring sign, spotty calcium).

resultsOf 160 patients (mean age: 53 ± 8 years, 40% women) 10.6% were diagnosed with ACS. The ACS rate in patients with hsTnI below the limit of detection (n = 9, 5.6%), intermediate (n = 139, 86.9%), and above the 99th percentile (n = 12, 7.5%) was 0%, 8.6%, and 58.3%, respectively. Absence of ≥50% stenosis and high-risk plaque ruled out ACS in patients with intermediate hsTnI (n = 87, 54.4%; ACS rate 0%), whereas patients with both ≥50% stenosis and high-risk plaque were at high risk (n = 13, 8.1%; ACS rate 69.2%) and patients with either ≥50% stenosis or high-risk plaque were at intermediate risk for ACS (n = 39, 24.4%; ACS rate 7.7%). hsTnI/advanced coronary CTA assessment significantly improved the diagnostic accuracy for ACS as compared to conventional troponin/traditional coronary CTA (area under the curve 0.84, 95% confidence interval [CI]: 0.80 to .88 vs. 0.74, 95% CI: 0.70 to 0.78; p < 0.001).

conclusionshsTnI at the time of presentation followed by early advanced coronary CTA assessment improves the risk stratification and diagnostic accuracy for ACS as compared to conventional troponin and traditional coronary CTA assessment. (Multicenter Study to Rule Out Myocardial Infarction/Ischemia by Cardiac Computed Tomography [ROMICAT-II]; NCT01084239).

Indexed as

Acute Coronary SyndromeAngina PectorisCoronary AngiographyCoronary Artery DiseaseCoronary StenosisCoronary VesselsTomography, X-Ray ComputedTroponin IAdultBiomarkersEmergency Service, HospitalFemaleHospitalizationHumansMaleMiddle AgedBiomarkersTroponin Iacute coronary syndromecoronary computed tomography angiographycoronary plaqueemergency departmenthighly sensitive troponinrisk stratification

Identifiers

PMID26476506
PMCPMC4644454
OpenAlexW1781839799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.